Market Focus

SeaWorld

SeaWorld saw its shares tank after it reported disappointing quarterly results. The theme park operator missed on both the top and bottom lines and its forecasting a drop in revenue and earnings for this year compared to 2013. The company says its attendance was hurt by questions about its treatments of captive Orcas, or killer whales. The stock tumbled about 33 percent to $18.90- its lowest level ever.

Deere

Deere’s profit slumped in its third quarter and the farming equipment maker is expecting weak sales ahead. It trimmed its outlook and will cut production. This as there’s been a slowdown in farming in the U.S. The stock was off by more than two percent to $84.49.

Canadian Solar

Canadian Solar rallied on strong earnings. The solar panel maker reversed its year ago loss by posting a quarterly profit as it sold more of its products at higher prices. It also said it expects shipments to rise further in the current quarter. Shares were 24 percent higher to $31.03.

Noodles & Co. 

Fast-casual chain Noodles & Co. saw its shares slide right after its late earning report. It announced lower-than-expected quarterly profits, hurt partly by a drop in same-store sales. The stock was down initially after-hours by as much as 18 percent. During the regular session the stock was down slightly to 25.21.

AOL

Shares of AOL moved higher on its plans to raise $300 million through convertible bonds. This is the first time the company has issued bonds since it was spun off from Time Warner in 2009. Now there’s speculation that AOL is planning a big acquisition. The stock was slightly higher to $42.46.

Tyson Foods & Hillshire Brands

The Justice Department wants more information about the planner merger of Tyson Foods and Hillshire Brands. The companies say the request relates to a very small portion of the planned combination. Shares of Tyson were up slightly to $37.66. Hillshire also edged up a fraction to $62.78.

Myriad Genetics

Weak earnings and a lower than expected forecast for full-year profits pressured Myriad Genetics today. The maker of diagnostic tests partly blamed the termination of its contract with insurer Horizon Blue Cross for the disappointing guidance. The stock plunged 7.5 percent to $36.04.

This entry was posted in Market Focus. Bookmark the permalink.

Leave a Reply